Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Diemert

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Vaccine|March 26, 2011
Selection and quantification of infection endpoints for trials of vaccines against intestinal helminthsNeal Alexander, Bonnie Cundill, Lorenzo Sabatelli, et al.
Microbial Pathogenesis|April 17, 2025
Manufacture of Necator americanus as an infectious challenge agent: Accelerating human hookworm vaccine developmentGuacyara Erwin, Larissa Scholte, Rafaela Saes, et al.
Vaccine|October 20, 2023
Vaccine value profile for HookwormKarl Philipp Puchner, Maria Elena Bottazzi, Victoria Periago, et al.
Plos Neglected Tropical Diseases|October 18, 2021
Parasitic helminth infections in humans modulate Trefoil Factor levels in a manner dependent on the species of parasite and age of the hostBabatunde Adewale, Jonathan R Heintz, Christopher F Pastore, et al.
The Journal of Allergy and Clinical Immunology|June 30, 2012
Molecular mechanisms of hookworm disease: stealth, virulence, and vaccinesMark S Pearson, Leon Tribolet, Cinzia Cantacessi, et al.
Open Forum Infectious Diseases|May 22, 2018
Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine DevelopmentDavid Diemert, Doreen Campbell, Jill Brelsford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccinationKazutoyo Miura, Hong Zhou, Samuel E Moretz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2008
Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine designJunhui Duan, Jianbing Mu, Mahamadou Ali Thera, et al.
The American Journal of Tropical Medicine and Hygiene|January 1, 2008
Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensityAlassane Dicko, Issaka Sagara, David Diemert, et al.
Clinical Pharmacology and Therapeutics|July 13, 2021
Differences in the Platelet mRNA Landscape Portend Racial Disparities in Platelet Function and Suggest Novel Therapeutic TargetsKaitlin Garofano, C Sehwan Park, Cristina Alarcon, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Vaccine|March 26, 2011
Selection and quantification of infection endpoints for trials of vaccines against intestinal helminthsNeal Alexander, Bonnie Cundill, Lorenzo Sabatelli, et al.
Microbial Pathogenesis|April 17, 2025
Manufacture of Necator americanus as an infectious challenge agent: Accelerating human hookworm vaccine developmentGuacyara Erwin, Larissa Scholte, Rafaela Saes, et al.
Vaccine|October 20, 2023
Vaccine value profile for HookwormKarl Philipp Puchner, Maria Elena Bottazzi, Victoria Periago, et al.
Plos Neglected Tropical Diseases|October 18, 2021
Parasitic helminth infections in humans modulate Trefoil Factor levels in a manner dependent on the species of parasite and age of the hostBabatunde Adewale, Jonathan R Heintz, Christopher F Pastore, et al.
The Journal of Allergy and Clinical Immunology|June 30, 2012
Molecular mechanisms of hookworm disease: stealth, virulence, and vaccinesMark S Pearson, Leon Tribolet, Cinzia Cantacessi, et al.
Open Forum Infectious Diseases|May 22, 2018
Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine DevelopmentDavid Diemert, Doreen Campbell, Jill Brelsford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccinationKazutoyo Miura, Hong Zhou, Samuel E Moretz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2008
Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine designJunhui Duan, Jianbing Mu, Mahamadou Ali Thera, et al.
The American Journal of Tropical Medicine and Hygiene|January 1, 2008
Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensityAlassane Dicko, Issaka Sagara, David Diemert, et al.
Clinical Pharmacology and Therapeutics|July 13, 2021
Differences in the Platelet mRNA Landscape Portend Racial Disparities in Platelet Function and Suggest Novel Therapeutic TargetsKaitlin Garofano, C Sehwan Park, Cristina Alarcon, et al.
Pageof 4